Filing Details
- Accession Number:
- 0001651844-21-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 11:09:02
- Reporting Period:
- 2021-04-21
- Accepted Time:
- 2021-04-27 11:09:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-21 | 2,000 | $2.09 | 3,512,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-21 | 6,000 | $2.08 | 3,518,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-21 | 4,100 | $2.08 | 3,522,650 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-21 | 900 | $2.08 | 3,523,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 7,000 | $2.07 | 3,530,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 1,900 | $2.13 | 3,532,450 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 3,100 | $2.11 | 3,535,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 5,000 | $2.05 | 3,540,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 4,949 | $2.09 | 3,545,499 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 51 | $2.08 | 3,545,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 800 | $2.10 | 3,546,350 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 2,900 | $2.09 | 3,549,250 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 1,100 | $2.09 | 3,550,350 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-22 | 200 | $2.09 | 3,550,550 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
